Skip to main content
. 2018 Apr 24;10(2):53. doi: 10.3390/pharmaceutics10020053

Figure 2.

Figure 2

In vitro release profiles of ITZ from different formulations in simulated gastrointestinal fluid (Mean ± S.D., n = 3). (A) In vitro release profiles of ITZ from pure ITZ, Sporanox®, and ASD (amorphous solid dispersion) without surfactant; In vitro release profiles of ITZ from ASD with different amount of (B) TPGS (d-α-tocopheryl polyethylene glycol 1000 succinate), (C) SDS (sodium dodecyl sulfate), and (D) Poloxamer 188.